EG23684A - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
EG23684A
EG23684A EG4697A EG4697A EG23684A EG 23684 A EG23684 A EG 23684A EG 4697 A EG4697 A EG 4697A EG 4697 A EG4697 A EG 4697A EG 23684 A EG23684 A EG 23684A
Authority
EG
Egypt
Prior art keywords
pharmaceuticals
Prior art date
Application number
EG4697A
Other languages
English (en)
Inventor
Michael J Greenway
Original Assignee
Smithklin Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithklin Beecham Plc filed Critical Smithklin Beecham Plc
Application granted granted Critical
Publication of EG23684A publication Critical patent/EG23684A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EG4697A 1996-01-16 1997-01-14 Pharmaceuticals EG23684A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
EG23684A true EG23684A (en) 2007-05-09

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
EG4697A EG23684A (en) 1996-01-16 1997-01-14 Pharmaceuticals

Country Status (38)

Country Link
US (1) US6765007B1 (es)
EP (1) EP0874632B1 (es)
JP (2) JP4711360B2 (es)
KR (1) KR100338829B1 (es)
CN (1) CN1132582C (es)
AP (2) AP747A (es)
AR (1) AR005456A1 (es)
AT (1) ATE220910T1 (es)
AU (1) AU713090B2 (es)
BG (1) BG63488B1 (es)
BR (1) BR9706982A (es)
CY (1) CY2390B1 (es)
CZ (1) CZ287205B6 (es)
DE (1) DE69714215T2 (es)
DK (1) DK0874632T3 (es)
DZ (1) DZ2159A1 (es)
EA (1) EA001946B1 (es)
EG (1) EG23684A (es)
ES (1) ES2180922T3 (es)
GB (1) GB9600847D0 (es)
HK (1) HK1016473A1 (es)
HU (1) HU225472B1 (es)
IL (1) IL124913A0 (es)
MX (1) MX9805713A (es)
MY (1) MY127527A (es)
NO (1) NO315689B1 (es)
NZ (1) NZ326769A (es)
OA (1) OA10812A (es)
PE (1) PE35498A1 (es)
PL (1) PL187291B1 (es)
PT (1) PT874632E (es)
SK (1) SK282132B6 (es)
TR (1) TR199800954T2 (es)
TW (1) TW434016B (es)
UA (1) UA63897C2 (es)
UY (2) UY24437A1 (es)
WO (1) WO1997025990A1 (es)
ZA (1) ZA97310B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
WO2010151893A1 (en) 2009-06-26 2010-12-29 Taris Biomedical, Inc. Implantable drug delivery devices and methods of making the same
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
EP0182024B1 (en) 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
EP0586523A4 (en) 1991-05-15 1995-11-29 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
HK1016473A1 (en) 1999-11-05
GB9600847D0 (en) 1996-03-20
ZA97310B (en) 1997-10-23
CZ225498A3 (cs) 1998-12-16
DZ2159A1 (fr) 2002-12-01
NO983259L (no) 1998-07-15
MY127527A (en) 2006-12-29
UA63897C2 (en) 2004-02-16
KR100338829B1 (ko) 2002-07-18
BG63488B1 (bg) 2002-03-29
HUP9901021A3 (en) 2000-08-28
CY2390B1 (en) 2004-09-10
NO315689B1 (no) 2003-10-13
EP0874632B1 (en) 2002-07-24
AP1114A (en) 2002-10-18
UY24556A1 (es) 2001-08-27
ATE220910T1 (de) 2002-08-15
IL124913A0 (en) 1999-01-26
OA10812A (en) 2003-01-29
BG102638A (en) 1999-07-30
AU1541897A (en) 1997-08-11
CZ287205B6 (en) 2000-10-11
DK0874632T3 (da) 2002-11-11
WO1997025990A1 (en) 1997-07-24
AP747A (en) 1999-05-03
PL327922A1 (en) 1999-01-04
EA199800573A1 (ru) 1999-02-25
AP9801298A0 (en) 1998-09-30
PL187291B1 (pl) 2004-06-30
DE69714215D1 (de) 2002-08-29
US6765007B1 (en) 2004-07-20
CN1132582C (zh) 2003-12-31
EP0874632A1 (en) 1998-11-04
ES2180922T3 (es) 2003-02-16
SK282132B6 (sk) 2001-11-06
HUP9901021A2 (hu) 1999-08-30
JP2000503311A (ja) 2000-03-21
CN1208350A (zh) 1999-02-17
NO983259D0 (no) 1998-07-15
KR19990077229A (ko) 1999-10-25
SK95698A3 (en) 1999-01-11
TW434016B (en) 2001-05-16
BR9706982A (pt) 1999-07-20
JP4711360B2 (ja) 2011-06-29
EA001946B1 (ru) 2001-10-22
AR005456A1 (es) 1999-06-23
PT874632E (pt) 2002-10-31
MX9805713A (es) 1998-10-31
NZ326769A (en) 2000-05-26
UY24437A1 (es) 1997-06-06
JP2009091362A (ja) 2009-04-30
AU713090B2 (en) 1999-11-25
PE35498A1 (es) 1998-08-07
DE69714215T2 (de) 2003-01-23
HU225472B1 (en) 2006-12-28
AP9700911A0 (en) 1997-01-31
TR199800954T2 (xx) 1998-10-21

Similar Documents

Publication Publication Date Title
GB9615202D0 (en) Pharmaceuticals
GB9601544D0 (en) Pharmaceuticals
EG23684A (en) Pharmaceuticals
GB9618967D0 (en) Pharmaceuticals
ZA972684B (en) Pharmaceuticals
GB9612937D0 (en) Pharmaceuticals
GB9606744D0 (en) Pharmaceuticals
GB9601546D0 (en) Pharmaceuticals
GB9615272D0 (en) Pharmaceuticals
GB9615273D0 (en) Pharmaceuticals
GB9602133D0 (en) Pharmaceuticals
GB9615274D0 (en) Pharmaceuticals
GB9602403D0 (en) Pharmaceuticals
GB9604447D0 (en) Pharmaceuticals
GB9604453D0 (en) Pharmaceuticals
GB9604671D0 (en) Pharmaceuticals
GB9612939D0 (en) Pharmaceuticals
GB9604909D0 (en) Pharmaceuticals
GB9615253D0 (en) Pharmaceuticals
GB9612938D0 (en) Pharmaceuticals
ZA9710729B (en) Pharmaceuticals
GB9605568D0 (en) Pharmaceuticals
GB9615203D0 (en) Pharmaceuticals
GB9606414D0 (en) Pharmaceuticals
GB9615275D0 (en) Pharmaceuticals